The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure

Can J Cardiol. 2001 Dec:17 Suppl E:5E-25E.
[Article in English, French]
No abstract available

Publication types

  • Consensus Development Conference
  • Guideline
  • Practice Guideline
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Ambulatory Care Facilities
  • Angioplasty, Balloon, Coronary
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Arrhythmias, Cardiac / complications
  • Arrhythmias, Cardiac / therapy
  • Cardiotonic Agents / therapeutic use
  • Coronary Artery Bypass
  • Digitalis Glycosides / therapeutic use
  • Drug Interactions
  • Exercise Therapy / methods
  • Health Behavior
  • Health Education / methods
  • Heart Failure / complications
  • Heart Failure / diagnosis
  • Heart Failure / prevention & control
  • Heart Failure / therapy*
  • Heart Transplantation
  • Heart-Assist Devices
  • Humans
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Mitral Valve / surgery
  • Myocardial Revascularization
  • Risk Factors
  • Ventricular Dysfunction, Left / complications
  • Ventricular Dysfunction, Left / therapy

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Cardiotonic Agents
  • Digitalis Glycosides
  • Mineralocorticoid Receptor Antagonists